VANNI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.914
EU - Europa 432
AS - Asia 171
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.521
Nazione #
US - Stati Uniti d'America 1.912
IT - Italia 202
SG - Singapore 121
IE - Irlanda 68
CN - Cina 29
DE - Germania 29
RU - Federazione Russa 28
GB - Regno Unito 19
SE - Svezia 18
UA - Ucraina 18
CZ - Repubblica Ceca 9
KR - Corea 9
BE - Belgio 8
FR - Francia 8
FI - Finlandia 6
NL - Olanda 6
AT - Austria 3
IN - India 3
PL - Polonia 3
AU - Australia 2
DK - Danimarca 2
IL - Israele 2
IR - Iran 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 2.521
Città #
Wilmington 521
Houston 396
Chandler 209
Woodbridge 150
Fairfield 116
Singapore 102
Dublin 56
Ashburn 52
Rome 52
Ann Arbor 45
Cambridge 36
Medford 36
Seattle 36
Lawrence 17
New York 16
Santa Clara 16
Dearborn 15
Naples 15
Beijing 14
Brno 9
Jacksonville 9
Milan 9
Brussels 8
London 7
Munich 7
Palermo 7
Philadelphia 7
Arosio 6
Moscow 6
San Diego 6
Seoul 6
Bologna 5
Turin 5
Cagliari 4
Catania 4
Center 4
Colorado Springs 4
Helsinki 4
Redwood City 4
Chieti 3
Genoa 3
Inverigo 3
Monterotondo 3
Nanjing 3
Alessandria 2
Bari 2
Cinisello Balsamo 2
Council Bluffs 2
Deiva Marina 2
Dong Ket 2
Falls Church 2
Hounslow 2
Lyon 2
Massafra 2
Mülheim 2
Nocera Superiore 2
Ozzano dell'Emilia 2
Palo Alto 2
Potenza 2
Qazvin 2
Seriate 2
Striano 2
Trasacco 2
Verona 2
Warsaw 2
Wuhan 2
Almere Stad 1
Amsterdam 1
Andria 1
Arezzo 1
Baveno 1
Beograd 1
Chions 1
Delhi 1
Dubai 1
Espoo 1
Frankfurt am Main 1
Garden City 1
Hanover 1
Harbin 1
Hebei 1
Hefei 1
Jinan 1
Kemerovo 1
Kilburn 1
Lanzhou 1
Los Angeles 1
Miami 1
Montalto Uffugo 1
Mumbai 1
Nanchang 1
Norwalk 1
Novokuznetsk 1
Nuremberg 1
Opera 1
Padova 1
Paris 1
Paterno 1
Pescara 1
Porto Sant'elpidio 1
Totale 2.114
Nome #
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia 322
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 290
RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models 240
Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum 230
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 218
Studio dell'espressione di SNAP-25 e SNAP-23 nella corteccia cerebellare 180
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 170
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 137
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 131
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 95
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 88
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 88
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 84
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 70
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 63
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 52
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 45
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 45
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 32
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 27
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 9
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 8
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 8
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 6
Totale 2.638
Categoria #
all - tutte 9.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 0 0 0 39 59 55 44 59 56 39 43
2020/2021550 40 42 44 40 79 55 143 49 16 19 18 5
2021/2022246 8 9 4 24 1 53 17 7 18 25 13 67
2022/2023460 43 55 37 64 19 103 32 16 21 5 17 48
2023/2024175 31 11 11 1 10 31 10 18 12 3 6 31
2024/2025283 19 138 43 33 50 0 0 0 0 0 0 0
Totale 2.638